{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:17:51Z","timestamp":1779279471570,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s11102-026-01651-3","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T11:37:43Z","timestamp":1775302663000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adverse hepato-biliary-pancreatic events in acromegaly patients treated with first generation somatostatin receptor ligands"],"prefix":"10.1007","volume":"29","author":[{"given":"Francesco","family":"Ferra\u00f9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena Sofia","family":"Blanca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Ragonese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Alibrandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Arnaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi Simone","family":"Aversa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Cuboni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Grottoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Giorgino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Leonardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ylenia","family":"Alessi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla Paola","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giordana","family":"Siracusano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Squadrito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Carosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Mangone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Cannav\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,4]]},"reference":[{"key":"1651_CR1","doi-asserted-by":"publisher","unstructured":"Giustina A, Colao A, Acromegaly (2025) N Engl J Med. ;393(19):1926\u20131939. https:\/\/doi.org\/10.1056\/NEJMra2409076. PMID: 41223366","DOI":"10.1056\/NEJMra2409076"},{"issue":"1","key":"1651_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1210\/er.2002-0022","volume":"25","author":"A Colao","year":"2004","unstructured":"Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25(1):102\u2013152","journal-title":"Endocr Rev"},{"issue":"11","key":"1651_CR3","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41574-025-01148-2","volume":"21","author":"S Melmed","year":"2025","unstructured":"Melmed S, di Filippo L, Fleseriu M, Mercado M, Karavitaki N, Gurnell M, Salvatori R, Tsagarakis S, Losa M, Maffei P, Pereira AM, Geer EB, Katznelson L, van der Lely AJ, Bollerslev J, Esposito D, Webb SM, Zatelli MC, Valassi E, Neggers S, Chanson P, Ho KKY, Ioachimescu AG, Biller BMK, Samson SL, Kaiser UB, Schilbach K, Luque RM, Casanueva FF, Shimon I, Boguszewski CL, Biermasz N, Colao A, Pirchio R, Lamberts SWJ, Kadioglu P, Buchfelder M, Frara S, Chiloiro S, Petersenn S, Gadelha MR, Puig-Domingo M, Luger A, Brue T, Beckers A, Ferone D, Clemmons DR, Greenman Y, Marazuela M, Mortini P, Strasburger CJ, Giustina A (2025) Consensus on acromegaly therapeutic outcomes: an update. Nat Rev Endocrinol 21(11):718\u2013737. https:\/\/doi.org\/10.1038\/s41574-025-01148-2Epub 2025 Aug 13. PMID: 40804505","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"1651_CR4","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","volume":"14","author":"S Melmed","year":"2018","unstructured":"Melmed S, Bronstein MD, Chanson P, Klibanski A, Casanueva FF, Wass JAH, Strasburger CJ, Luger A, Clemmons DR, Giustina A (2018) A consensus statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol 14(9):552\u2013561","journal-title":"Nat Rev Endocrinol"},{"key":"1651_CR5","doi-asserted-by":"crossref","unstructured":"Colao A, Grasso LFS, Giustina A, Melmed S, Chanson P, Pereira AM, Pivonello R (2019) Acromegaly. Nat Rev Dis Primers. ;5(1):20. Erratum in: Nat Rev Dis Primers. 2019;5(1):72","DOI":"10.1038\/s41572-019-0071-6"},{"issue":"11","key":"1651_CR6","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1007\/BF03345632","volume":"31","author":"RS Auriemma","year":"2008","unstructured":"Auriemma RS, Pivonello R, Galdiero M, De Martino MC, De Leo M, Vitale G, Lombardi G, Colao A (2008) Octreotide-LAR vs lanreotide-SR as first-line therapy for acromegaly: a retrospective, comparative, head-to-head study. J Endocrinol Invest 31(11):956\u2013965","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"1651_CR7","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s11102-010-0282-z","volume":"14","author":"M Fleseriu","year":"2011","unstructured":"Fleseriu M (2011) Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature review. Pituitary 14(2):184\u2013193","journal-title":"Pituitary"},{"issue":"5","key":"1651_CR8","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.3390\/ijms21051682","volume":"21","author":"M Gomes-Porras","year":"2020","unstructured":"Gomes-Porras M, C\u00e1rdenas-Salas J, \u00c1lvarez-Escol\u00e1 C (2020) Somatostatin analogs in clinical practice: a review. Int J Mol Sci 21(5):1682","journal-title":"Int J Mol Sci"},{"issue":"9","key":"1651_CR9","first-page":"2768","volume":"80","author":"CB Newman","year":"1995","unstructured":"Newman CB, Melmed S, Snyder PJ, Young WF, Boyajy LD, Levy R, Stewart WN, Klibanski A, Molitch ME, Gagel RF (1995) Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients\u2013a clinical research center study. J Clin Endocrinol Metab 80(9):2768\u20132775","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1651_CR10","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1517\/14740338.2015.1059817","volume":"14","author":"LF Grasso","year":"2015","unstructured":"Grasso LF, Auriemma RS, Pivonello R, Colao A (2015) Adverse events associated with somatostatin analogs in acromegaly. Expert Opin Drug Saf 14(8):1213\u20131226","journal-title":"Expert Opin Drug Saf"},{"issue":"6","key":"1651_CR11","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/annonc\/mdh216","volume":"15","author":"K Oberg","year":"2004","unstructured":"Oberg K, Kvols L, Caplin M, Delle Fave G, de Herder W, Rindi G, Ruszniewski P, Woltering EA, Wiedenmann B (2004) Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. Ann Oncol 15(6):966\u2013973","journal-title":"Ann Oncol"},{"issue":"7","key":"1651_CR12","first-page":"1042","volume":"90","author":"JS Redfern","year":"1995","unstructured":"Redfern JS, Fortuner WJ 2 (1995) Octreotide-associated biliary tract dysfunction and gallstone formation: pathophysiology and management. Am J Gastroenterol 90(7):1042\u20131052","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1651_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1586\/17446651.2.2.129","volume":"2","author":"R Cozzi","year":"2007","unstructured":"Cozzi R, Attanasio R (2007) Octreotide for acromegaly. Expert Rev Endocrinol Metab 2(2):129\u2013145","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"1","key":"1651_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/BF03348589","volume":"13","author":"E Roti","year":"1990","unstructured":"Roti E, Minelli R, Gardini E, Salvi M, Bianconi L, Balducci L, Manfredi A, Braverman LE (1990) Chronic treatment with a long-acting somatostatin analogue in a patient with intestinal carcinoid tumor: occurrence of cholelithiasis. J Endocrinol Invest 13(1):69\u201372","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"1651_CR15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/gut.2004.048074","volume":"54","author":"AF Hofmann","year":"2005","unstructured":"Hofmann AF (2005) Increased deoxycholic acid absorption and gall stones in acromegalic patients treated with octreotide: more evidence for a connection between slow transit constipation and gall stones. Gut 54(5):575\u2013578","journal-title":"Gut"},{"issue":"5","key":"1651_CR16","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1136\/gut.2003.028431","volume":"54","author":"LA Thomas","year":"2005","unstructured":"Thomas LA, Veysey MJ, Murphy GM, Russell-Jones D, French GL, Wass JA, Dowling RH (2005) Octreotide induced prolongation of colonic transit increases faecal anaerobic bacteria, bile acid metabolising enzymes, and serum deoxycholic acid in patients with acromegaly. Gut 54(5):630\u2013635","journal-title":"Gut"},{"issue":"9 Suppl 2","key":"1651_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/0026-0495(92)90027-8","volume":"41","author":"RH Dowling","year":"1992","unstructured":"Dowling RH, Hussaini SH, Murphy GM, Besser GM, Wass JA (1992) Gallstones during octreotide therapy. Metabolism 41(9 Suppl 2):22\u201333","journal-title":"Metabolism"},{"issue":"2","key":"1651_CR18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.5009\/gnl.2012.6.2.172","volume":"6","author":"LM Stinton","year":"2012","unstructured":"Stinton LM, Shaffer EA (2012) Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver 6(2):172\u2013187","journal-title":"Gut Liver"},{"issue":"7","key":"1651_CR19","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.3748\/wjg.14.1023","volume":"14","author":"GH Elta","year":"2008","unstructured":"Elta GH (2008) Sphincter of Oddi dysfunction and bile duct microlithiasis in acute idiopathic pancreatitis. World J Gastroenterol 14(7):1023\u20131026","journal-title":"World J Gastroenterol"},{"key":"1651_CR20","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1007\/BF03346419","volume":"31","author":"R Attanasio","year":"2008","unstructured":"Attanasio R, Mainolfi A, Grimaldi F et al (2008) Somatostatin analogs and gallstones: A retrospective survey on a large series of acromegalic patients. J Endocrinol Invest 31:704\u2013710","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"1651_CR21","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3390\/biom12040550","volume":"12","author":"H Sun","year":"2022","unstructured":"Sun H, Warren J, Yip J, Ji Y, Hao S, Han W, Ding Y (2022) Factors influencing gallstone formation: A review of the literature. Biomolecules 12(4):550","journal-title":"Biomolecules"},{"issue":"4","key":"1651_CR22","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.bpg.2014.07.013","volume":"28","author":"L Bonfrate","year":"2014","unstructured":"Bonfrate L, Wang DQ, Garruti G, Portincasa P (2014) Obesity and the risk and prognosis of gallstone disease and pancreatitis. Best Pract Res Clin Gastroenterol 28(4):623\u2013635","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"3","key":"1651_CR23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/jmwh.12959","volume":"64","author":"A Littlefield","year":"2019","unstructured":"Littlefield A, Lenahan C (2019) Cholelithiasis: presentation and management. J Midwifery Womens Health 64(3):289\u2013297","journal-title":"J Midwifery Womens Health"},{"issue":"2","key":"1651_CR24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s11102-020-01102-7","volume":"24","author":"N Prencipe","year":"2021","unstructured":"Prencipe N, Bona C, Cuboni D, Parasiliti-Caprino M, Berton AM, Fenoglio LM, Gasco V, Ghigo E, Grottoli S (2021) Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment. Pituitary 24(2):242\u2013251","journal-title":"Pituitary"},{"issue":"1","key":"1651_CR25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1136\/gut.36.1.126","volume":"36","author":"SH Hussaini","year":"1995","unstructured":"Hussaini SH, Pereira SP, Murphy GM, Kennedy C, Wass JA, Besser GM, Dowling RH (1995) Composition of gall bladder stones associated with octreotide: response to oral ursodeoxycholic acid. Gut 36(1):126\u2013132","journal-title":"Gut"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01651-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01651-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01651-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:01:48Z","timestamp":1779278508000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-026-01651-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1651"],"URL":"https:\/\/doi.org\/10.1007\/s11102-026-01651-3","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}